-+ 0.00%
-+ 0.00%
-+ 0.00%

Labcorp releases transcript of Q2 2026 earnings call webcast prepared remarks

PUBT·07/30/2026 13:36:01
Listen to the news
Labcorp releases transcript of Q2 2026 earnings call webcast prepared remarks
  • Labcorp’s Q2 2026 results webcast drew Chairman and CEO Adam Schechter, CFO Julia Wang, SVP IR Dewey Steadman.
  • Q2 revenue rose 6% to USD 3.7 billion; adjusted operating margin widened 70 bps to 15.8%; adjusted EPS increased 15% to USD 4.99.
  • Diagnostics revenue grew 5.5% to USD 2.9 billion; adjusted operating margin improved to 18% from 17.6%.
  • Biopharma Laboratory Services revenue climbed 6.5% to USD 836 million; margin expanded to 17% from 15.7%; book-to-bill 1.14; backlog USD 8.7 billion.
  • Raised 2026 guidance: revenue growth 5.4%-6.3%; adjusted EPS USD 18.10-18.55; free cash flow USD 1.24-1.36 billion; buyback authorization lifted by USD 1 billion to USD 1.4 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.